How the DOT Will Make Planes More Accessible for People With Disabilities

Airlines will likely be required to expand their lavatory size to be more accessible for passengers in wheelchairs over the next three years. 
A long-standing argument over bathroom size and entertainment options finally found resolution. 

We all know airplanes aren’t the best places to stretch or move around with ease. For passengers who use wheelchairs, though, it can be a nightmare. More and more stories have come out recently about the unfair and uncomfortable setup on planes for those with special and medical accessibility needs, and the U.S. Department of Transportation just announced they’re finally doing something about it.
While airlines have complied with the regulations set out by the Americans with Disabilities Act (ADA) of 1990, previously unconsidered issues like inadequate bathroom size have been brought to light thanks to social media. Now, the DOT’s ACCESS Advisory Committee—which includes airline representatives, flight attendants, and people with disabilities—revealed they plan to make bathrooms on single-aisle aircrafts (a.k.a. six-abreast seating in a cabin below 13 feet of width), which account for most domestic and short-haul international flights, more accessible for those in wheelchairs or who need extra assistance on board. 
“The agreement reached by the ACCESS Advisory Committee is an important step towards ensuring that air travelers with disabilities have equal access to air transportation,” said U.S. Transportation Secretary Anthony Foxx in a release. “It is unfair to expect individuals with limited mobility to refrain from using the restroom when they fly on single aisle aircraft, particularly since single aisle aircraft are increasingly used for longer flights.” 
While the committee understands that the current size of the lavatory would not change immediately, they do want to require airlines to “take a number of steps to improve the accessibility of these lavatories short of increasing their size three years after the effective date of the final rule.” Along with better bathroom accessibility, they also want better “maneuverability standards for the aircraft’s on-board wheelchair.” In the future, they want all single-aisle aircrafts with more than 125 passengers to be required to have the more accessible, larger bathroom currently found on twin-aisle aircraft. It was not specified whether or not new planes would have to be built or if current ones would have to be reconstructed and who would take on that cost.
And that’s not the only issue the committee is proposing to tackle. They also want to require airlines to offer entertainment options for people who are blind, deaf, or hard of hearing, as most airlines generally do not provide in-flight entertainment with audio description or closed captioning. “It is also unfair for passengers who are deaf or blind not to be able to enjoy the same entertainment that is available to other passengers,” the committee added in the release. It's unclear how this would effect in-flight announcements, but current standards state that flight attendants can ask disabled passengers if they need to be notified separately if something is said over the public address speaker.This is a big win for the ACCESS Advisory Committee, as the decision was reached after seven months of negotiations. The committee is preparing to issue a notice of proposed rule-making based on this agreement in July 2017. But, one issue is still outstanding: reaching an agreement on on-board service animals

Post Polio Litaff, Association A.C _APPLAC Mexico

6 key numbers in the fight to end polio

We are close to eradicating a human disease for only the second time in history. A global public-private partnership has reduced the poliovirus caseload by 99.9% over the last 30 years, but there’s still plenty of work to do. 
Even before we reach that milestone, the knowledge and infrastructure built to fight polio is being repurposed to take on other global challenges. 
3 countries where polio is still endemic 
Fewer than 40 children were paralysed by polio in 2016, the lowest number in history. This is a dramatic decrease from the estimated 350,000 cases per year in 125 countries that the world saw in 1985 - the year that Rotary International initiated a worldwide effort to eradicate this terrible disease. 
In 1988, Rotary was joined in the effort by WHO, the U.S. Centers for Disease Control, UNICEF (and more recently the Gates Foundation) to create the Global Polio Eradication Initiative (GPEI). 
Today the virus is limited to a few areas in just three countries – Pakistan, Afghanistan and Nigeria.
Image: Rotary International
In response, Nigeria intensified surveillance activities to pinpoint where the virus is circulating.
In Pakistan, innovative tactics are being used to focus polio immunization drives. Health workers are trained in the use of cellphone data reporting, which allows real-time recording of immunization coverage and public health surveys of populations. 
In Afghanistan, the program continues to adapt in order to reach the maximum number of children possible despite a volatile security situation.
155: the number of countries involved in largest coordinated vaccine switch in history
There are three different strains of the poliovirus. Once a strain is eliminated (type 2 was officially eradicated in September 2015), we have to match our vaccines to the remaining strains to protect children globally. 
This transition is a massive undertaking, requiring significant funding and coordination to accomplish global health feats that have never been attempted.
To give you a sense of scale, the largest and fastest globally coordinated vaccine switch in history (to target poliovirus types 1 and 3) was successfully conducted over two weeks in April 2016, with 155 countries taking part.
Image: Rotary International
$60 billion: the cost of infectious disease epidemics per year
The spread of infectious diseases is consistently among the world’s top 10 risks in terms of impact. The eradication of polio will mean no child will ever be paralyzed by this debilitating disease again. However, we must use the knowledge and infrastructure built up over many years by the GPEI to take on other global health threats.
Dramatic progress on improving children’s health beyond polio is already underway – resulting in a decreasing number of children dying from other preventable diseases in countries with strong polio infrastructure. Polio drops are now often delivered alongside essential services including nutrition support, primary health care and other vaccines.
Image: Rotary International
By identifying the overlap between what the polio programme has to offer and country-level priorities for strengthening health systems, we can make a lasting difference to global health overall, and significantly reduce the gap in the impact of infectious diseases between middle income and poorer countries.
20 million: the number of volunteers participating
Since the GPEI was launched in 1988, Rotary and other volunteers have raised funds, built awareness, and advocated for their national governments to support polio eradication.
Image: Rotary International
A volunteer can administer the two drops of oral polio vaccine to a child, and participate in National Immunization Days, which attempt to vaccinate every child under five years of age in endemic or at-risk countries. Millions of health workers are also helping us reach children who have never before been vaccinated.
$1.5 billion: the amount needed to eradicate polio
This may sound expensive, but, in the words of Dr. Jonas Salk, who invented the first effective polio vaccine, “which is more important, the human value of the dollar, or the dollar value of the human?”
Funding has already contributed to many important successes of our programme. In 2016, Rotary funded the work of 52,676 vaccinators and 2528 supervisors in Iraq to keep up strong immunization coverage. Investments made to polio eradication are also contributing to future health goals by documenting the knowledge, lessons learned and assets of the programme.
Image: Rotary International
Funds also make possible the programme’s extensive surveillance and laboratory network to tell us where polio does (and does not) exist – a painstaking task given only one in 200 cases of polio results in paralysis. This network is already instrumental for taking on public health challenges beyond polio, such as Ebola.
While we undoubtedly still have work to do and funds to raise, we are confident in the good work of our volunteers and members to get us to our goal of eradication. Read and be inspired by their stories and successes here – a world free from polio is certainly within our reach.
4: the factor by which health savings exceed the cost of polio eradication
Immunization as a public health investment is incredibly good value. Every dollar spent on vaccinations in the US saves $3 in direct healthcare costs and $10 societally. A polio-free world will reap financial savings and reduce healthcare costs by up to $50 billion through 2035. In fact, we’ve already saved $27 billion since the GPEI was launched, and low-income countries account for 85% of the savings, not to mention the immeasurable alleviation of human suffering.
Image: Rotary International
Conversely, if we allow polio to spread again, it would cost upwards of $35 billionmore in treatment expenses and economic losses, so it’s a no-brainer that we have to commit all our resources to finish the job once and for all.

Post Polio Litaff, Association A.C _APPLAC Mexico

How to Spot and Prevent Deep Vein Thrombosis

When the Clot Thickens

Illustration of the veins in the lower leg and a close-up of a blood clot lodged in a vein.
Lots of things can cause pain and swelling in your leg. But if your symptoms stem from a blood clot deep in your leg, it can be dangerous. Blood clots can happen to anyone, anytime. But some people are at increased risk. Taking steps to reduce your chances of a blood clot forming in your veins can help you avoid potentially serious problems.
Blood clots can arise anywhere in your body. They develop when blood thickens and clumps together. When a clot forms in a vein deep in the body, it’s called deep vein thrombosis. Deep vein blood clots typically occur in the lower leg or thigh. 
“Deep vein thrombosis has classic symptoms—for example swelling, pain, warmth, and redness on the leg,” says Dr. Andrei Kindzelski, an NIH blood disease expert. “But about 30–40% of cases go unnoticed, since they don’t have typical symptoms.” In fact, some people don’t realize they have a deep vein clot until it causes a more serious condition. 
Deep vein clots—especially those in the thigh—can break off and travel through the bloodstream. If a clot lodges in an artery in the lungs, it can block blood flow and lead to a sometimes-deadly condition called pulmonary embolism. This disorder can damage the lungs and reduce blood oxygen levels, which can harm other organs as well. 
Some people are more at risk for deep vein thrombosis than others. “Usually people who develop deep vein thrombosis have some level of thrombophilia, which means their blood clots more rapidly or easily,” Kindzelski says. Getting a blood clot is usually the first sign of this condition because it’s hard to notice otherwise. In these cases, lifestyle can contribute to a blood clot forming—if you don’t move enough, for example. Your risk is higher if you’ve recently had surgery or broken a bone, if you’re ill and in bed for a long time, or if you’re traveling for a long time (such as during long car or airplane rides). 
Having other diseases or conditions can also raise your chances of a blood clot. These include a stroke, paralysis (an inability to move), chronic heart disease, high blood pressure, surgical procedure, or having been recently treated for cancer. Women who take hormone therapy pills or birth control pills, are pregnant, or within the first 6 weeks after giving birth are also at higher risk. So are those who smoke or who are older than 60. But deep vein thrombosis can happen at any age.
You can take simple steps to lower your chances for a blood clot. Exercise your lower leg muscles if you’re sitting for a long time while traveling. Get out of bed and move around as soon as you’re able after having surgery or being ill. The more active you are, the better your chance of avoiding a blood clot. Take any medicines your doctor prescribes to prevent clots after some types of surgery. 
A prompt diagnosis and proper treatment can help prevent the complications of blood clots. See your doctor immediately if you have any signs or symptoms of deep vein thrombosis or pulmonary embolism (see the Wise Choices box). A physical exam and other tests can help doctors determine whether you’ve got a blood clot. 
There are many ways to treat deep vein thrombosis. Therapies aim to stop the blood clot from getting bigger, prevent the clot from breaking off and moving to your lungs, or reduce your chance of having another blood clot. NIH scientists continue to research new medicines and better treatment options.
If you think you may be at risk for deep vein thrombosis, talk with your doctor.  

Post Polio Litaff, Association A.C _APPLAC Mexico

How the U.S. Battled Polio

| June 22, 2011

Talk to anyone old enough to remember polio epidemics in the U.S., and you will see the fear in their eyes as they talk about those terrible and unsettling times. For decades, no one knew why thousands of children would suddenly be stricken—usually in midsummer—with many dying or left permanently paralyzed.
Today, most of us in the U.S. don’t even think about polio. But if you go to villages in India’s Bihar Province or the northern states of Nigeria, or the southern part of Afghanistan, you will see that very same fear in the eyes of parents who worry that their child might be next.
I’m a dogged advocate for polio eradication and have written about it in many other articles on the Gates Notes. We are very close to ridding the world of this terrible disease once and for all. It will take focus and commitment to get it done, but I am confident we can.
That’s why I’m a fan of David Oshinsky’s insightful book, Polio: An American Story. (I’m not alone here, as it received the Pulitzer Prize for history in 2006.) It is a fascinating account of the search for a vaccine to stop the polio epidemics that swept the U.S. in the first half of the 20th century, and the remarkable efforts that led to its successful eradication from the U.S. and most other countries. Reading Oshinsky’s book a few years ago broadened my appreciation of the challenges associated with global health issues and influenced the decision that Melinda and I made to make polio eradication the top priority of the foundation, as well as my own personal priority.
Oshinsky retraces the steps of researchers trying to puzzle together how to create an effective vaccine. He’s a gifted storyteller who makes complex scientific subjects easy to understand and also captures the mood of a country terrorized by an invisible and little-understood disease. He describes in meticulous but never-boring detail the people and politics associated with one of the most important medical breakthroughs in history. 
I found it interesting that the first recorded polio epidemic in the U.S. didn’t occur until 1894, in rural Vermont. By 1908, Karl Landsteiner, a Viennese researcher who later won a Nobel Prize for his discovery of the different human blood types, isolated the poliovirus by injecting monkeys with an emulsion from the spinal cord of a boy who had just died of polio. It was one of several important breakthroughs in the early 20th century battle against killer infectious diseases, including malaria, tuberculosis, diphtheria, typhoid, and syphilis.
In 1916, a polio outbreak in New York City quickly spread to adjacent states. Despite intensive sanitation measures of the kind that had helped control other epidemic diseases such as cholera and typhoid fever, 27,000 people died that summer. In New York City, 80 percent of those who died were under five. 
I knew that Franklin Delano Roosevelt contracted polio, but did not realize until reading Oshinsky’s book how significant an influence FDR had on the search for a vaccine. He was struck in the fall of 1921 while on a family vacation in Canada. The news stunned Americans, who at the time believed the disease mainly occurred among poor children in slums. FDR was 39 and from a wealthy New York family.
For thousands of polio victims, Roosevelt symbolized that life could go on for those disabled by the disease. He helped found the National Foundation for Infantile Paralysis, now known as the March of Dimes, which provided aid to victims and funded polio research. I was impressed that even as president, FDR would often respond personally to letters sent to him by other victims. Yet, Roosevelt also went to great lengths—abetted by a cooperative press corps—to hide the fact that he needed leg braces and handrails to stand, and a wheel chair to get around. I can’t imagine an American president being able to do that today, but FDR was greatly admired at a time when the nation was dealing with a world war and the Great Depression. Somehow, he persuaded the media that obscuring the extent of his disability was necessary to reassure the public that he was healthy and capable of holding public office.
I was also fascinated by the media savvy and marketing sophistication of the March of Dimes, which used famous Hollywood actors to get out its message and was the first philanthropic organization to introduce the idea that millions of Americans—not just the wealthy—could play an important role in helping solve big social problems. In 1938, Americans mailed nearly 2.7 million dimes directly to the White House in support of that year’s March of Dimes campaign.
We sometimes take for granted the speed of scientific breakthroughs today. Yet, Oshinky’s book reminded me of the painstaking efforts scientists often must undertake. Forty years after the polio virus was discovered, scientists still didn’t know what caused it. Theories ranged from rotten fruit to houseflies to contaminated milk. They didn’t know the mechanism by which it attacked the central nervous system. They didn’t know if there was just one type of polio, or many. And they didn’t know how to grow poliovirus safely, and in large enough quantities, to produce vaccines.
Also, researchers were divided over whether a “live-virus” vaccine or a “killed-virus” vaccine would be more effective. Most virologists believed a live-virus vaccine would stimulate higher antibody levels in the blood and create a lasting immunity. Advocates of the killed-virus vaccine believed it could be just as effective, and would eliminate any risk that someone receiving an immunization could contract polio.
Jonas Salk, a young researcher at the University of Pittsburgh, was one of those who believed a killed-virus vaccine would work. It had, after all, been effective against cholera, typhoid, and diphtheria. From 1949 to 1951, Salk and his team conducted extensive testing on thousands of monkeys, using samples from human polio victims and from monkeys who had contracted the virus after being injected with the human samples. Salk’s work confirmed what had been suspected but not yet proven—all of the identified and tested strains of poliovirus fit into one of three distinct types. 
About the same time, John Enders, a researcher at Harvard, figured out how to grow poliovirus that would be safe and could be mass produced. But scientists were still stymied over how the virus was transmitted and traveled through the body. Several prominent researchers had long believed that it entered through the nose and traveled directly to the central nervous system, bypassing the bloodstream. If that was the case, a vaccine that stimulated antibodies in the bloodstream would have done no good.
Two scientists working independently, Dorothy Horstmann at Yale and David Bodian at Johns Hopkins, upended the prevailing thinking with a breakthrough discovery. Previous researchers had been unable to detect poliovirus in the blood because they were not looking for it soon enough. Horstmann and Bodian discovered that the poliovirus is in the bloodstream for only a brief period of incubation before the body’s immune system creates antibodies that destroy it. 
Salk was relentless in his pursuit of a vaccine. He began human trials against the backdrop of the worst outbreak of polio on record in the U.S.—57,000 cases in 1952. By the spring of 1954, more than 1.3 million children had taken part in the largest vaccine trial in history. It took a year for the results to be reported, and when they were, church bells tolled, factory whistles rung, and then-President Dwight Eisenhower—a war hero—broke down in tears.
Although not 100 percent effective, the Salk vaccine was considered a huge success and a great relief for an edgy nation. In 1956, the number of polio cases in the U.S. dropped by 50 percent compared to the year before, and by another 50 percent the following year. 
Meanwhile, Sabin was about to undertake the largest medical experiment in world history—a live-virus vaccine administered to 10 million children in Russia. It, too, proved a success. Considered more effective and easier to administer than the Salk vaccine, Sabin’s oral vaccine won out by 1963. 
Oshinsky’s narrative ends at about this point, but the quest to completely eradicate polio is still ongoing. In 1987, the World Health Organization launched a global initiative to eradicate polio worldwide. Since that time, about 2.5 billion children have been vaccinated, and the number of polio cases has decreased by 99 percent. Last year there were fewer than 1,500 cases in just four countries—India, Nigeria, Pakistan, and Afghanistan. 
While this is fantastic progress, the last remaining cases pose a serious danger. If not completely eliminated, polio will spread back into countries where it has previously been eradicated, killing and paralyzing perhaps hundreds of thousands of children.
The foundation is deeply involved in this final push, and I am personally committed to doing what I can to rid the world of this dreaded disease once and for all.

Post Polio Litaff, Association A.C _APPLAC Mexico

15 Things Your Thyroid Can Affect

Maybe you've heard people say, "I'm tired because I have a thyroid problem." Or, "I see an endocrinologist because I have thyroid issues." But how much do you really know about your thyroid? 
The thyroid is a small gland that is butterfly shaped and located at the base of the neck, just below the Adam's apple. It's part of the endocrine system, which helps coordinate many of your body's activities. The gland makes hormones that regulate your metabolism. But when it's not working right, your body can be affected in various ways.
You don't produce enough hormone.
Hypothyroidism is also known as Hashimoto's disease or Hashimoto's thyroiditis. It is most common in middle-aged women, but Hashimoto's disease can happen at any age. Here, your immune system mistakenly attacks and slowly destroys the thyroid gland and its ability to make hormones. Treatment may include taking daily medication (which you'll likely need for the rest of your life since it restores adequate hormone levels) and monitoring the dosage to ensure you're taking the right amount. Your doctor may pass on medication and take a wait-and-see-approach. 
You produce too much hormone.
Hyperthyroidism is also known as Graves' disease. This autoimmune disorder happens when the body's immune system mistakenly attacks the thyroid gland. It's hereditary and is most common in women ages 20 to 30. Some treatments include radioactive iodine therapy (taking radioiodine orally), prescription antithyroid medications (which interfere with the thyroid's use of iodine to produce hormones), beta blockers (which block the effect of hormones on the body) or surgery to remove all or part of your thyroid. 
You have a goiter.A goiter is a noncancerous enlargement of the thyroid gland. It's often caused by a lack of iodine in your diet. It's most common in parts of the world that lack iodine-rich foods and are more common in women and after age 40. Treatments depends on your symptoms, the size of the goiter and the underlying cause. Small goiters that aren't noticeable or problematic typically don't need treatment. 
You have a thyroid nodule.
Thyroid nodules are growths that form in or on the thyroid gland. They can be caused by Hashimoto's disease and iodine deficiency, though the causes aren't always known. Most are benign, but a small percentage of cases can be cancerous. They're more common in women, and your risk increases as you get older. Symptoms may resemble hyperthyroidism if you have abnormally high levels of the hormone in your bloodstream. Symptoms will be like hypothyroidism if the nodules are linked to Hashimoto's disease. Treatment depends on the type of thyroid nodule. 
Your sleep changes.
You've always been a good sleeper but suddenly can't sleep through the night? You may have an overactive thyroid, which is pumping out some hormones excessively. And that can overstimulate the central nervous system and lead to insomnia. You may also need more sleep than usual, feel tired despite a good night's sleep or have the urge to nap. That means you may have an underactive thyroid. 
Your hair is thinning.
Thinning hair, especially on the eyebrows, is a common sign of thyroid disease. An overactive or underactive thyroid affects your hair's growth cycle. Usually, most of your hair grows while some of it rests. But when your thyroid is out of order, too much hair rests at once. And that makes your hair look thinner. 
You're sweating excessively when you shouldn't be.
You're not even at the gym but you're sweating excessively. That's a common sign of a hyperactive thyroid. Since your hormone levels are higher than normal, you feel warm. 
Your skin is dry in the summer.
You may have hypothyroidism. Why? A slower metabolism can decrease sweating. And that means your skin has less moisture, making it dry. 
You suddenly feel anxious.
If you start feeling unsettled or anxious and you've never had that issue, you may have a hyperactive thyroid. Because your thyroid hormone levels are high, you feel anxious, nervous, irritable, shaky or jittery. 
You have unexplained weight gain.
When you have a lack of hormones due to an underactive thyroid, your metabolism decreases and you burn fewer calories. So, your pants may feel snug, though your exercise or eating habits have remained the same. 
You aren't gaining weight.On the flip side, you may be losing weight without changing what you eat or how you exercise. Here, you may have an increased metabolism, due to an overactive thyroid. You're hungrier and eating more, but you aren't gaining weight.
You're forgetful.
Some people say they're in a brain fog when they have an underactive thyroid. Others say they have subtle memory loss, overall mental fatigue or difficulty concentrating. That can all be blamed on an underactive thyroid.
Your bowel movements change.
You may have an underactive thyroid if you're frequently constipated. The thyroid helps regulate your digestive track. But if you don't produce enough thyroid hormones, things can get backed up. And if you have an overactive thyroid, you'll have regular bowel movements but need to go more frequently since everything is sped up.
You have too much energy.
Your body processes speed up when you have too many hormones. You may feel like you've had too much coffee or feel like you're having heart palpitations, even when you're relaxed. 
Your periods have changed.
You may not be producing enough hormones if your periods have become longer, heavier or closer together. You may be producing too many hormones if they occur further apart or have gotten lighter.
Post Polio Litaff, Association A.C _APPLAC Mexico

In Fight Against Troubling Viruses, Vaccines Offer Hope

From VOA Learning English, this is the Health & Lifestyle report.
In 2016, three viruses made news, and they present difficult problems for health officials in the New Year.
One virus threatens babies in many parts of the world. Another has reappeared in an African nation. And a third is one of the deadliest viruses of modern times.
The three viruses are Zika, polio and HIV.
However, in 2016 scientists and researchers from all over the world worked to make progress against those viruses and to develop better ways to control them.
Zika virus linked to birth defects
The spread of the Zika virus caused public health officials in many nations to put in place strong measures to control its spread.
Brazil, which hosted the 2016 Summer Olympic Games, was hit hard by the virus. Health officials warned pregnant women against traveling to the sporting event.
Zika is usually a mild illness. It is so mild that most people who are infected do not know they have it.
However, in the past two years in the Western Hemisphere, Zika has been linked to babies to being born with extremely small heads. This condition is called microcephaly. The international medical community found that this link to birthdefects makes Zika a very dangerous virus.
In this Feb. 4, 2016 photo, Luana Vitoria, who was born with microcephaly, cries during a physical therapy session at a treatment center in Racife, Brazil. (AP Photo)
In this Feb. 4, 2016 photo, Luana Vitoria, who was born with microcephaly, cries during a physical therapy session at a treatment center in Racife, Brazil. (AP Photo)
Zika first appeared in Uganda more than 60 years ago. It is spread by mosquitos and by sex.
The virus recently appeared in Brazil. Then cases appeared in other countries to the North. Cases were reported in the United States in the southern state of Florida. Health officials in Texas are also concerned the virus might be spreading there.

Dr. Anthony Costello is with the World Health Organization. He says that even one child affected by zika has a very big impact on community resources and a family's ability to deal with the results. Costello considers the disabilities caused by zika to be a “huge blow” to families. 

"It is a public health problem of huge concern for the world. Sixty-nine countries have seen the Zika virus emerge in the last two years. We are talking about a virus that causes brain damage and potentially lifelong disability which is a huge blow to families."
Doctors can only advise women to be careful. They advise women not to travel to areas where the virus is spreading, to avoid mosquito bites or to delay pregnancy.
Currently there is no vaccine against Zika. However, one could be available by 2018.
Polio appears again in Africa
The return of a virus once thought to be gone or eliminated made news in 2016.
The polio virus returned in Africa’s most populated country - Nigeria. Continuing violence in the northern part of Nigeria had made it difficult for all children to get vaccinated. At a time when Nigeria was thought to be almost polio-free, three children were diagnosed with the virus.
In August 2016, an emergency polio vaccination campaign took place in parts of Nigeria that were newly freed from Boko Haram Islamic extremists, who oppose efforts to block the crippling disease. (AP Photo)
In August 2016, an emergency polio vaccination campaign took place in parts of Nigeria that were newly freed from Boko Haram Islamic extremists, who oppose efforts to block the crippling disease. (AP Photo)
Polio continues to exists in another conflict area: along the border of Pakistan and Afghanistan.
But vaccination efforts continue to give health officials hope that polio can finally be eliminated.
Polio infections have decreased by 99 percent since 1988. In that year, there were about 350,000 cases. In 2016, there were fewer than 40.
Top health official suggests HIV vaccine could be near
In December, Dr. Anthony Fauci of the National Institutes of Health discussed testing of an experimental vaccine for HIV, the virus that causes AIDS.
Testing on a vaccine started in South Africa. The National Institutes of Health is partly funding the effort. However, Fauci warns that the process will take time and effort.

"An HIV vaccine is not going to be easy. We may not even know if we're going to get a vaccine."

He adds improvements in treatments for AIDS have lengthened the lives of those who have the disease.

"Today, the combinations of therapies we have for individuals - for someone who is in their 20s and gets infected and comes in and gets on a combination of drugs - you could predict that they would live an additional 50 years, 5-0. That is one of the most extraordinary advances in the transition from basic research to an applicable intervention in any field of medicine."

An effective HIV vaccine could finally mean the end for the deadly virus. HIV has infected more than 70 million people and has killed 35 million people over the past 50 years.
I’m Anna Matteo.

Carol Person reported this story from Washington, D.C. for VOA News. Anna Matteo adapted it for Learning English. Mario Ritter edited it.

Post Polio Litaff, Association A.C _APPLAC Mexico

Trump's Meeting With Wakefield Rattles Vaccine Supporters Was it a signal of new administration's attitude toward vaccines?

  • Managing Editor, MedPage Today
Recent news reports disclosed that Donald Trump met during the summer with a group of anti-vaccine activists including the movement's most prominent leader, Andrew Wakefield, MBBS, whose now-retracted publications first linked vaccines to autism risk. Trump also made remarks during the campaign expressing doubt about vaccine safetyand effectiveness.
MedPage Today asked more than a dozen specialists in infectious disease and public health whether they thought the Wakefield meeting might signal a new, more skeptical attitude in Washington toward vaccines.

Some said it is a definite cause for worry.
"I think it is fair to say that everyone involved with vaccines (public health, pediatricians, family docs, patient advocacy groups, etc.) is very concerned!" said William Schaffner, MD, of Vanderbilt University, in an email. "This is potentially serious stuff."
Matthew Boulton, MD, MPH, of the University of Michigan, expanded on that theme. "The fact that [Trump] met with a doctor (Andrew Wakefield) to discuss vaccine policy who was shown to have blatantly falsified data in his study linking autism and vaccines and who has since been drummed out of the scientific and medical communities is rather astounding. I think the anti-vaccine crowd will definitely be emboldened with Trump in the White House."
Boulton added that he expects "the anti-vaccine community will grow more vocal and assertive because they perceive [Trump] as an ally."
Similarly, Anne Gershon, MD, of Columbia University, told MedPage Today that she was "horrified" to learn of the Wakefield encounter. "Given the appointment of Tom Price to head HHS and the planned attacks on the CDC, I strongly fear for control of infections by vaccines," she said in an email. "The failure to appreciate science... is frightening. If we can't control these falsehoods about vaccines, we are going to have epidemics of measles, rubella (and congenital rubella) and other 'childhood' infections that are even worse in adolescents than in children."

But other experts took more of a wait-and-see attitude.
"I think [Trump] is very unpredictable. ​I don't see him as science driven but as a practical economic issue vaccination makes sense," said John Sinnott, MD, of the University of South Florida in Tampa.
David Topham, PhD, of the University of Rochester, argued, too, that Trump is a pragmatist, not an ideologue. "It's one thing to engage with certain constituents during the election, and to imply support to win the greatest number of supporters, it is another thing entirely to face down overwhelming evidence that vaccines save lives and that they are not linked to autism."
"Optimistically," said Carol J. Baker, MD, of Baylor College of Medicine in Houston, "I would think Trump as a businessman and Price as a physician would clearly see the cost saving and great health benefit of vaccines to our population (real data not opinion) combined with the increasingly robust facts concerning safety."
And several respondents expect a much clearer signal of the new administration's approach to public health when Trump's pick to head the CDC is announced. "It is hard to know how concerned to be until we hear who is being considered for CDC director," said Emily Martin, PhD, MPH, of the University of Michigan.

That nomination has not yet been made and the Washington rumor mill has so far been silent about it.
Roger Sergel, Executive Producer, contributed reporting to this article. 

    Post Polio Litaff, Association A.C _APPLAC Mexico


    Post Polio Syndrome

    VDPV Vaccine

    The Polio Crusade

    THE POLIO CRUSADE IN AMERICAN EXPERIENCE A GOOD VIDEO THE STORY OF THE POLIO CRUSADE pays tribute to a time when Americans banded together to conquer a terrible disease. The medical breakthrough saved countless lives and had a pervasive impact on American philanthropy that ... Continue reading..

    Erradicación de La poliomielitis